Mortality in mechanically ventilated patients with COVID-19: a systematic review

References

• Phua J, Weng L, Ling L, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020 May;8(5):506–517.
   PubMed Web of Science ®Google Scholar
• Hu Y, Sun J, Dai Z, et al. Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol. 2020 Jun;127:104371.
   PubMed Web of Science ®Google Scholar
• [cited 2020 Aug 20]. Available from:https://www.covid19treatmentguidelines.nih.gov/critical-care/oxygenation-and-ventilation/
   Google Scholar
• Alhazzani W, Moller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020 May;46(5):854–887.
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Rubenfeld GD, Thompson BT. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533. Force* TADT.
   PubMed Web of Science ®Google Scholar
• Fan E, Beitler JR, Brochard L, et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med. 2020;8(8):816–821.
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6):1099–1102.
   PubMed Web of Science ®Google Scholar
• Robba C, Battaglini D, Ball L, et al. Distinct phenotypes require distinct respiratory management strategies in severe COVID-19. Respir Physiol Neurobiol. 2020;279:103455.
   PubMed Web of Science ®Google Scholar
• Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016 Feb 23;315(8):788–800.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 Jul 21;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Abdallah K, Hamed F, Rahman N, et al. Characteristics of critically ill patients infected with COVID-19 in Abu Dhabi, United Arab Emirates. Anaesth Crit Care Pain Med. 2020 Jul;39(4):1.
   PubMed Web of Science ®Google Scholar
• Alattar R, Ibrahim TBH, Shaar SH, et al. Tocilizumab for the treatment of severe coronavirus disease 2019. J Med Virol. 2020 May 5;92(10):2042–2049.
   PubMed Web of Science ®Google Scholar
• Almazeedi S, Al-Youha S, Jamal MH, et al. Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. EClinicalMedicine. 2020 Jul;24:100448.
   PubMedGoogle Scholar
• Amit M, Sorkin A, Chen J, et al. Clinical course and outcomes of severe Covid-19: a national scale study. J Clin Med. 2020 Jul 18;9(7):7.
   Web of Science ®Google Scholar
• Antinori S, Cossu MV, Ridolfo AL, et al. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: clinical outcome and differences in post-treatment hospitalisation status. Pharmacol Res. 2020 Aug;158:104899.
   PubMed Web of Science ®Google Scholar
• Arapovic J, Skocibusic S. The first two months of the COVID-19 pandemic in Bosnia and Herzegovina: single-center experience. Bosn J Basic Med Sci. 2020 Aug 3;20(3):396–400.
   PubMed Web of Science ®Google Scholar
• Argenziano MG, Bruce SL, Slater CL, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020 May;29(369):m1996.
   Google Scholar
• Auld SC, Caridi-Scheible M, Blum JM, et al. ICU and ventilator mortality among critically ill adults with coronavirus disease 2019. Crit Care Med. 2020 Sep;48(9):e799-e804.
   Google Scholar
• Barrasa H, Rello J, Tejada S, et al. SARS-CoV-2 in Spanish intensive care units: early experience with 15-day survival in Vitoria. Anaesth Crit Care Pain Med. 2020 Apr;39(5):9.
   PubMed Web of Science ®Google Scholar
• Berenguer J, Ryan P, Rodriguez-Bano J, et al. Characteristics and predictors of death among 4,035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect. 2020 Nov;26(11):1525-1536.
   Web of Science ®Google Scholar
• Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the seattle region - case series. N Engl J Med. 2020 May 21;382(21):2012–2022.
   PubMed Web of Science ®Google Scholar
• Boileve A, Stoclin A, Barlesi F, et al. COVID-19 management in a cancer center: the ICU storm. Support Care Cancer. 2020 Jul;28(10):31.
   Web of Science ®Google Scholar
• Brill SE, Jarvis HC, Ozcan E, et al. COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease. BMC Med. 2020 Jun 25;18(1):194.
   PubMed Web of Science ®Google Scholar
• Cao J, Tu WJ, Cheng W, et al. Clinical features and short-term outcomes of 102 patients with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020 Jul 28;71(15):748–755.
   PubMed Web of Science ®Google Scholar
• Cardoso FS, Pereira R, Germano N. Liver injury in critically ill patients with COVID-19: a case series. Crit Care. 2020 May 5;24(1):190.
   PubMedGoogle Scholar
• Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 Aug;63(8):1500–1515.
   PubMed Web of Science ®Google Scholar
• Cen Y, Chen X, Shen Y, et al. Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study. Clin Microbiol Infect.
   Google Scholar
• Chen F, Sun W, Sun S, et al. Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China. Clin Transl Med. 2020 Jun;4(2):e40.
   Web of Science ®Google Scholar
• Chen FF, Zhong M, Liu Y, et al. The characteristics and outcomes of 681 severe cases with COVID-19 in China. J Crit Care. 2020 Jul 8;60:32–37.
   PubMed Web of Science ®Google Scholar
• Chen L, Yu J, He W, et al. Risk factors for death in 1859 subjects with COVID-19. Leukemia. 2020 Aug;34(8):2173–2183.
   PubMed Web of Science ®Google Scholar
• Chen T, Dai Z, Mo P, et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study. J Gerontol A Biol Sci Med Sci.
   Web of Science ®Google Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 Mar;26(368):m1091.
   Web of Science ®Google Scholar
• Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020 Jun 6;395(10239):1763–1770.
   PubMed Web of Science ®Google Scholar
• Demoule A, Vieillard Baron A, Darmon M, et al. High flow nasal canula in critically ill severe COVID-19 patients. Am J Respir Crit Care Med.
   Google Scholar
• Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020 May;22(369):m1985.
   Google Scholar
• Eimer J, Vesterbacka J, Svensson AK, et al. Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study. J Intern Med. 2020 Aug;289(3):3.
   Web of Science ®Google Scholar
• Erkurt MA, Sarici A, Berber I, et al. Life-saving effect of convalescent plasma treatment in covid-19 disease: clinical trial from eastern Anatolia. Transfus Apher Sci. 2020 Jun;59:102867.
   PubMed Web of Science ®Google Scholar
• Esnault P, Cardinale M, Hraiech S, et al. High respiratory drive and excessive respiratory efforts predict relapse of respiratory failure in critically ill patients with COVID-19. Am J Respir Crit Care Med. 2020 Aug;202(8):5.
   Web of Science ®Google Scholar
• Faqihi F, Alharthy A, Alodat M, et al. Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: a pilot study. J Crit Care. 2020 Jul;60:31.
   Web of Science ®Google Scholar
• Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med.
   Web of Science ®Google Scholar
• Fominskiy EV, Scandroglio AM, Monti G, et al. Prevalence, characteristics, risk factors, and outcomes of invasively ventilated COVID-19 patients with acute kidney injury and renal replacement therapy. Blood Purif. 2020;13:1–8.
   Google Scholar
• Gao S, Jiang F, Jin W, et al. Risk factors influencing the prognosis of elderly patients infected with COVID-19: a clinical retrospective study in Wuhan, China. Aging (Albany NY). 2020 Jul 11;12(13):12504–12516.
   PubMedGoogle Scholar
• Gavin W, Campbell E, Zaidi SA, et al. Clinical characteristics, outcomes and prognosticators in adult patients hospitalized with COVID-19. Am J Infect Control. 2020 Jul;49(2):8.
   PubMedGoogle Scholar
• Gayam V, Chobufo MD, Merghani MA, et al. Clinical characteristics and predictors of mortality in African-Americans with COVID-19 from an inner-city community teaching hospital in New York. J Med Virol.
   Web of Science ®Google Scholar
• Van Gerwen M, Alsen M, Little C, et al. Risk factors and outcomes of COVID-19 in New York City; a retrospective cohort study. J Med Virol. 2020 Jul;93(2):24.
   Web of Science ®Google Scholar
• Goldman JD, Lye DCB, Hui DS, et al. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med.
   Web of Science ®Google Scholar
• Gotzinger F, Santiago-Garcia B, Noguera-Julian A et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study Lancet Child Adolesc Health.
   Google Scholar
• Grasselli G, Greco M, Zanella A, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med. 2020 Jul;180(10):15.
   Web of Science ®Google Scholar
• Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020 Jun 11;382(24):2327–2336.
   PubMed Web of Science ®Google Scholar
• Gupta S, Hayek SS, Wang W, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med.
   Web of Science ®Google Scholar
• Halvatsiotis P, Kotanidou A, Tzannis K, et al. Demographic and clinical features of critically ill patients with COVID-19 in Greece: the burden of diabetes and obesity. Diabetes Res Clin Pract. 2020 Jul 17;166:108331.
   PubMed Web of Science ®Google Scholar
• Hu HT, Xu S, Wang J, et al. Respiratory support in severely or critically ill ICU patients with COVID-19 in Wuhan, China. Curr Med Sci. 2020 Aug;40(4):7.
   Web of Science ®Google Scholar
• Hua J, Qian C, Luo Z, et al. Invasive mechanical ventilation in COVID-19 patient management: the experience with 469 patients in Wuhan. Crit Care. 2020 Jun 16;24(1):348.
   PubMed Web of Science ®Google Scholar
• Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020 May 14;41(19):1821–1829.
   PubMed Web of Science ®Google Scholar
• Javanian M, Bayani M, Shokri M, et al. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study. Rom J Intern Med. 2020 Sep 1;58(3):161–167.
   PubMed Web of Science ®Google Scholar
• Jordan SC, Zakowski P, Tran HP, et al. Compassionate use of tocilizumab for treatment of SARS-CoV-2 pneumonia. Clin Infect Dis.
   Web of Science ®Google Scholar
• Karagiannidis C, Mostert C, Hentschker C, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med.
   Web of Science ®Google Scholar
• Kato H, Shimizu H, Shibue Y, et al. Clinical course of 2019 novel coronavirus disease (COVID-19) in individuals present during the outbreak on the Diamond Princess cruise ship. J Infect Chemother. 2020 Aug;26(8):865–869.
   PubMed Web of Science ®Google Scholar
• Khalil K, Agbontaen K, McNally D, et al. Clinical characteristics and 28-day mortality of medical patients admitted with COVID-19 to a central London teaching hospital. J Infect. 2020 Sep;81(3):e85–e89.
   PubMed Web of Science ®Google Scholar
• Kim L, Garg S, O’Halloran A, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the U.S. coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network (COVID-NET). Clin Infect Dis. 2020 Jul 16. DOI:10.1093/cid/ciaa1012.
   Web of Science ®Google Scholar
• Knorr JP, Colomy V, Mauriello CM, et al. Tocilizumab in patients with severe COVID-19: a single-center observational analysis. J Med Virol. 2020 Jun;92(11):17.
   PubMed Web of Science ®Google Scholar
• Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020 Jun 20;395(10241):1907–1918.
   PubMed Web of Science ®Google Scholar
• Lagi F, Piccica M, Graziani L, et al. Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020. Euro Surveill. 2020 Apr;25(17):17.
   Google Scholar
• Lee JY, Kim HA, Huh K, et al. Risk factors for mortality and respiratory support in elderly patients hospitalized with COVID-19 in Korea. J Korean Med Sci. 2020 Jun 15;35(23):e223.
   PubMed Web of Science ®Google Scholar
• Li J, Li M, Zheng S, et al. Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19. Biomark Med.
   Web of Science ®Google Scholar
• Li L, Yang L, Gui S, et al. Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan, China. Theranostics. 2020;10(14):6113–6121.
   PubMed Web of Science ®Google Scholar
• Li Q, Cao Y, Chen L, et al. Hematological features of persons with COVID-19. Leukemia. 2020 Aug;34(8):2163–2172.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang S, Wu Z, et al. Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study. Ann Intensive Care. 2020 Jul 31;10(1):99.
   PubMed Web of Science ®Google Scholar
• Liu J, Dong YQ, Yin J, et al. Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: a retrospective study. Medicine (Baltimore). 2020 Jun 26;99(26):e21012.
   PubMed Web of Science ®Google Scholar
• Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020 Jul;18(7):1743–1746.
   PubMed Web of Science ®Google Scholar
• Mani VR, Kalabin A, Valdivieso SC, et al. New York Inner city hospital COVID-19 experience and current data: retrospective analysis at the epicenter of the American coronavirus outbreak. J Med Internet Res. 2020 Jun;22(9):14.
   Web of Science ®Google Scholar
• Mehta V, Goel S, Kabarriti R, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020 Jul;10(7):935–941.
   PubMed Web of Science ®Google Scholar
• Mitra AR, Fergusson NA, Lloyd-Smith E, et al. Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series. CMAJ. 2020 Jun 29;192(26):E694–E701.
   PubMed Web of Science ®Google Scholar
• Moreno-Perez O, Andres M, Leon-Ramirez JM, et al. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: a retrospective cohort study. J Autoimmun. 2020 Jul;16:102523.
   Web of Science ®Google Scholar
• Morrison AR, Johnson JM, Griebe KM, et al. Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab. J Autoimmun. 2020 Jul;114:102512.
   PubMed Web of Science ®Google Scholar
• Mukhtar A, Lotfy A, Hasanin A, et al. Outcome of non-invasive ventilation in COVID-19 critically ill patients: a Retrospective observational Study. Anaesth Crit Care Pain Med. 2020 Jul;39(5):28.
   Web of Science ®Google Scholar
• Nadeem A, Hamed F, Saleh K, et al. ICU outcomes of COVID-19 critically ill patients: an international comparative study. Anaesth Crit Care Pain Med. 2020 Jul;39(4):3.
   Web of Science ®Google Scholar
• Otto WR, Geoghegan S, Posch LC, et al. The Epidemiology of SARS-CoV-2 in a Pediatric Healthcare Network in the United States. J Pediatric Infect Dis Soc.
   Google Scholar
• Paranjpe I, Fuster V, Lala A, et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020 Jul 7;76(1):122–124.
   PubMed Web of Science ®Google Scholar
• Pedersen HP, Hildebrandt T, Poulsen A, et al. Initial experiences from patients with COVID-19 on ventilatory support in Denmark. Dan Med J. 2020 Apr 27;67(5):5.
   Web of Science ®Google Scholar
• Pereira MR, Mohan S, Cohen DJ, et al. COVID-19 in solid organ transplant recipients: initial report from the US epicenter. Am J Transplant. 2020 Jul;20(7):1800–1808.
   PubMed Web of Science ®Google Scholar
• Perez-Guzman PN, Daunt A, Mukherjee S, et al. Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study. Clin Infect Dis.
   Google Scholar
• Perez-Saez MJ, Blasco M, Redondo-Pachon D, et al. Use of tocilizumab in kidney transplant recipients with COVID-19. Am J Transplant. 2020 Jul 12;20(11):3182–3190.
   PubMed Web of Science ®Google Scholar
• Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020 May;22(369):m1966.
   Google Scholar
• Philips K, Uong A, Buckenmyer T, et al. Rapid implementation of an adult coronavirus disease 2019 unit in a children’s hospital. J Pediatr. 2020 Jul;222:22–27.
   PubMed Web of Science ®Google Scholar
• Price CC, Altice FL, Shyr Y, et al. Tocilizumab treatment for cytokine release syndrome in hospitalized COVID-19 patients: survival and clinical outcomes. Chest. 2020 Jun;158(4):15.
   PubMed Web of Science ®Google Scholar
• Price-Haywood EG, Burton J, Fort D, et al. Hospitalization and mortality among black patients and white patients with Covid-19. N Engl J Med. 2020 Jun 25;382(26):2534–2543.
   PubMed Web of Science ®Google Scholar
• Primmaz S, Le Terrier C, Suh N, et al. Preparedness and reorganization of care for coronavirus disease 2019 patients in a Swiss ICU: characteristics and Outcomes of 129 Patients. Crit Care Explor. 2020 Aug;2(8):e0173.
   PubMedGoogle Scholar
• Quartuccio L, Sonaglia A, McGonagle D, et al. Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian Centre study on tocilizumab versus standard of care. J Clin Virol. 2020 Aug;129:104444.
   PubMed Web of Science ®Google Scholar
• Rastad H, Karim H, Ejtahed HS, et al. Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Diabetol Metab Syndr. 2020;12(1):57.
   PubMed Web of Science ®Google Scholar
• Rath D, Petersen-Uribe A, Avdiu A, et al. Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection. Clin Res Cardiol. 2020 Jun 14;109(12):1491–1499.
   PubMed Web of Science ®Google Scholar
• Group RC, Horby P, Lim WS, et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med.
   Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020 Apr;323(20):22.
   Web of Science ®Google Scholar
• Rojas-Marte G, Khalid M, Mukhtar O, et al. Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case-controlled study. QJM. 2020 Aug 1;113(8):546–550.
   PubMed Web of Science ®Google Scholar
• Salacup G, Lo KB, Gul F, et al. Characteristics and clinical outcomes of COVID-19 patients in an underserved-inner city population: a single tertiary center cohort. J Med Virol.
   Google Scholar
• Satlin MJ, Goyal P, Magleby R, et al. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease. PLoS One. 2020;15(7):e0236778.
   PubMed Web of Science ®Google Scholar
• Shang Y, Liu T, Wei Y, et al. Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine. 2020 Jul;24:100426.
   PubMedGoogle Scholar
• Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr.
   Google Scholar
• Shi S, Qin M, Cai Y, et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J. 2020 Jun 7;41(22):2070–2079.
   PubMed Web of Science ®Google Scholar
• Singer AJ, Morley EJ, Meyers K, et al. Cohort of four thousand four hundred four persons under investigation for COVID-19 in a New York hospital and predictors of ICU care and ventilation. Ann Emerg Med. 2020 May 11;76(4):394–404.
   PubMed Web of Science ®Google Scholar
• Somers EC, Eschenauer GA, Troost JP, et al. Tocilizumab for treatment of mechanically ventilated patients with COVID-19. Clin Infect Dis. 2020 Jul 11. DOI:10.1093/cid/ciaa954.
   PubMedGoogle Scholar
• Suleyman G, Fadel RA, Malette KM, et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan detroit. JAMA Network Open. 2020 Jun 1;3(6):e2012270.
   PubMed Web of Science ®Google Scholar
• Tatum D, Taghavi S, Houghton A, et al. Neutrophil-to-lymphocyte ratio and outcomes in louisiana Covid-19 patients. Shock. 2020 Jun 19;54(5):652–658.
   PubMed Web of Science ®Google Scholar
• Toniati P, Piva S, Cattalini M, et al. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020 Jul;19(7):102568.
   PubMed Web of Science ®Google Scholar
• Vanderburg S, Alipanah N, Crowder R, et al. Management and outcomes of critically-ill patients with COVID-19 pneumonia at a safety-net hospital in San Francisco, a region with early public health interventions: a case series. medRxiv. 2020 May 29. DOI:10.1101/2020.05.27.20114090.
   PubMedGoogle Scholar
• Wang D, Yin Y, Hu C, et al. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit Care. 2020 Apr 30;24(1):188.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang Z, Yu M, et al. 15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study. Intensive Care Med. 2020 Jul;46(7):1472–1474.
   PubMed Web of Science ®Google Scholar
• Wang T, Tang C, Chen R, et al. Clinical features of coronavirus disease 2019 patients with mechanical ventilation: a nationwide study in China. Crit Care Med. 2020 Jun 23;Publish Ahead of Print. DOI:10.1097/CCM.0000000000004473
   Google Scholar
• Wang Y, Lu X, Li Y, et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020 Jun 1;201(11):1430–1434.
   PubMed Web of Science ®Google Scholar
• Xu B, Fan CY, Wang AL, et al. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China. J Infect. 2020 Jul;81(1):e51–e60.
   PubMed Web of Science ®Google Scholar
• Xu J, Yang X, Yang L, et al. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care. 2020 Jul 6;24(1):394.
   PubMed Web of Science ®Google Scholar
• Xu PP, Tian RH, Luo S, et al. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study. Theranostics. 2020;10(14):6372–6383.
   PubMed Web of Science ®Google Scholar
• Yang K, Sheng Y, Huang C, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020 Jul;21(7):904–913.
   PubMed Web of Science ®Google Scholar
• Yang X, Cai S, Luo Y, et al. Extracorporeal membrane oxygenation for coronavirus disease 2019-induced acute respiratory distress syndrome: a multicenter descriptive study. Crit Care Med. 2020 May 18;Publish Ahead of Print. DOI:10.1097/CCM.0000000000004447
   Google Scholar
• Yuan M, Yin W, Tao Z, et al. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One. 2020;15(3):e0230548.
   PubMed Web of Science ®Google Scholar
• Zangrillo A, Beretta L, Scandroglio AM, et al. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc.
   Web of Science ®Google Scholar
• Zhang L, Li J, Zhou M, et al. Summary of 20 tracheal intubation by anesthesiologists for patients with severe COVID-19 pneumonia: retrospective case series. J Anesth. 2020 Aug;34(4):599–606.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Du Z, Zhu Y, et al. Evaluation of organ function in patients with severe COVID-19 infections. Med Clin (Barc). 2020 Jun 4;155(5):191–196.
   PubMed Web of Science ®Google Scholar
• Ziehr DR, Alladina J, Petri CR, et al. Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1560–1564.
   PubMed Web of Science ®Google Scholar
• Privitera D, Angaroni L, Capsoni N, et al. Flowchart for non-invasive ventilation support in COVID-19 patients from a northern Italy Emergency Department. Intern Emerg Med. 2020 Aug;15(5):767–771.
   PubMed Web of Science ®Google Scholar
• Crimi C, Noto A, Cortegiani A, et al. Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections. Minerva Anestesiol. 2020 Aug 5;86(11). DOI:10.23736/S0375-9393.20.14785-0.
   PubMed Web of Science ®Google Scholar
• Schunemann HJ, Khabsa J, Solo K, et al. Ventilation techniques and risk for transmission of coronavirus disease, including COVID-19: a living systematic review of multiple streams of evidence. Ann Intern Med. 2020 Aug 4;173(3):204–216.
   PubMed Web of Science ®Google Scholar
• Chen YH, Fang CT. Mortality from COVID-19: a cross-country comparison of containment versus mitigation strategy. J Formos Med Assoc.
   Web of Science ®Google Scholar
• Barrett K, Khan YA, Mac S, et al. Estimation of COVID-19-induced depletion of hospital resources in Ontario, Canada. CMAJ. 2020 Jun 15;192(24):E640–E646.
   PubMed Web of Science ®Google Scholar
• Feinstein MM, Niforatos JD, Hyun I, et al. Considerations for ventilator triage during the COVID-19 pandemic. Lancet Respir Med. 2020 Jun;8(6):e53.
   PubMed Web of Science ®Google Scholar
• Riccioni L, Bertolini G, Giannini A, et al. [Clinical ethics recommendations for the allocation of intensive care treatments, in exceptional, resource-limited circumstances.]. Recenti Prog Med. 2020 Apr;111(4):207–211.
   PubMedGoogle Scholar
• Armstrong RA, Kane AD, Cook TM. Decreasing mortality rates in ICU during the COVID-19 pandemic. Anaesthesia.
   Web of Science ®Google Scholar
• https://www.cebm.net/covid-19/covid-19-declining-admissions-to-intensive-care-units/[2020 Aug 20].
   Google Scholar
• REGN-COV2 Independent data monitoring committee recommends holding enrollment in hospitalized patients with high oxygen requirements and continuing enrollment in patients with low or no oxygen requirements [internet]. Regeneron: PR Newswire; 2020; 2020 Oct 30. Available from: https://investor.regeneron.com/news-releases/news-release-details/regn-cov2-independent-data-monitoring-committee-recommends
   Google Scholar
• Lilly Statement Regarding NIH’s ACTIV-3 Clinical trial [Internet]. lilly.com: eli Lilly and company; 2020; 2020 Oct 26. Available from: https://www.lilly.com/news/stories/statement-activ3-clinical-trial-nih-covid19
   Google Scholar
• Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269–271.
   PubMed Web of Science ®Google Scholar
• Pasquini Z, Montalti R, Temperoni C, et al. Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU. J Antimicrob Chemother. 2020 Aug 23;75(11):3359–3365.
   PubMed Web of Science ®Google Scholar
• Kalligeros M, Tashima KT, Mylona EK, et al. Remdesivir Use Compared to Supportive Care in Hospitalized Patients with Severe COVID-19: a Single-Center Experience. Open Forum Infect Dis. 2020;7(10). DOI:10.1093/ofid/ofaa319.
   Web of Science ®Google Scholar
• Pan H, Peto R, Karim QA, et al. Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results.
   Google Scholar
• https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs [2020 Aug 22].
   Google Scholar
• Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 — final report. N Engl J Med. 2020;383(19):1813–1826.
   PubMed Web of Science ®Google Scholar
• Spinner CD, Gottlieb RL, Criner GJ, et al. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial. JAMA. 2020 Aug 21;324(11):1048.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569–1578.
   PubMed Web of Science ®Google Scholar
• https://www.nih.gov/news-events/news-releases/nih-clinical-trial-hydroxychloroquine-potential-therapy-covid-19-begins [2020 Aug 20].
   Google Scholar
• Kalligeros M, Shehadeh F, Atalla E, et al. Hydroxychloroquine use in Hospitalized Patients with COVID-19: an observational matched cohort study. J Glob Antimicrob Resist. 2020 Aug 4;22:842–844.
   PubMed Web of Science ®Google Scholar
• Cavalcanti AB, Zampieri FG, Rosa RG, et al. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N Engl J Med. 2020 Jul 23;383(21):2041–2052.
   PubMed Web of Science ®Google Scholar
• Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020 Aug 6;383(6):517–525.
   PubMed Web of Science ®Google Scholar
• https://www.nih.gov/news-events/news-releases/nih-halts-clinical-trial-hydroxychloroquine [2020 Aug 20].
   Google Scholar
• Ip A, Berry DA, Hansen E, et al. Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study. PLoS One. 2020;15(8):e0237693.
   PubMed Web of Science ®Google Scholar
• Joyner MJ, Senefeld JW, Klassen SA, et al. Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience. medRxiv 2020.
   Google Scholar
• Joyner MJ, Carter RE, Senefeld JW, et al. Convalescent plasma antibody levels and the risk of death from Covid-19. N Engl J Med. 2021;384(11):1015–1027.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang W, Hu Y, et al. Effect of Convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA.
   Web of Science ®Google Scholar
• Salazar E, Christensen PA, Graviss EA, et al. Treatment of COVID-19 patients with convalescent plasma reveals a signal of significantly decreased mortality. Am J Pathol.
   Google Scholar
• https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-convalescent-plasma-potential-promising-covid-19-treatment [2020 Sept 2].
   Google Scholar
• Prescott HC, Rice TW. Corticosteroids in COVID-19 ARDS: evidence and Hope During the Pandemic. JAMA. 2020;324(13):1292.
   PubMed Web of Science ®Google Scholar
• Tomazini BM, Maia IS, Cavalcanti AB, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324(13):1307.
   PubMed Web of Science ®Google Scholar
• Dequin P-F, Heming N, Meziani F, et al. Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial. JAMA. 2020;324(13):1298.
   PubMed Web of Science ®Google Scholar
• Investigators T-C. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA.
   Web of Science ®Google Scholar
• Group TWREAfC-TW. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA.
   Web of Science ®Google Scholar
• Nelson BC, Laracy J, Shoucri S, et al. Clinical outcomes associated with methylprednisolone in mechanically ventilated patients with COVID-19. Clin Infect Dis. 2020 Aug 9. DOI:10.1093/cid/ciaa1163.
   Web of Science ®Google Scholar
• Jeronimo CMP, Farias MEL, Val FFA, et al. Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): a randomised, double-blind, phase iib, placebo-controlled trial. Clin Infect Dis. 2020:ciaa1177.
   Web of Science ®Google Scholar
• COVID-19 treatment guidelines for corticosteroids: national institute of health; [updated November 3, 2020;March 6, 2021]. Available from: https://www.covid19treatmentguidelines.nih.gov/immunomodulators/corticosteroids/
   Google Scholar
• [cited 2020 Sep 3]. Available from:https://www.who.int/publications/i/item/WHO-2019-nCoV-Corticosteroids-2020.1
   Google Scholar
• Horby PW, Pessoa-Amorim G, Peto L, et al. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. medRxiv 2021.
   Google Scholar
• Investigators R-C. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med. 2021.
   Web of Science ®Google Scholar
• Callejas Rubio JL, Luna Del Castillo JD, De La Hera Fernandez J, et al. Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection. Med Clin (Engl Ed). 2020 Aug 28;155(4):159–161.
   PubMedGoogle Scholar
• Rodriguez-Bano J, Pachon J, Carratala J, et al. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19). Clin Microbiol Infect.
   Web of Science ®Google Scholar
• The COVID-19 treatment guidelines panel’s statement on the use of tocilizumab for the treatment of COVID-19: national institute of health; 2021 [updated March 5, 2021;March 6, 2021]. Available from: https://www.covid19treatmentguidelines.nih.gov/statement-on-tocilizumab/
   Google Scholar
• Khamis F, Al-Zakwani I, Al Hashmi S, et al. Therapeutic plasma exchange in adults with severe COVID-19 infection. Int J Infect Dis. 2020 Jun 22;99:214–218.
   PubMed Web of Science ®Google Scholar
• Carfora V, Spiniello G, Ricciolino R, et al. Anticoagulant treatment in COVID-19: a narrative review. J Thromb Thrombolysis. 2020 Aug 18. DOI:10.1007/s11239-020-02242-0.
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020 Jun 16;75(23):2950–2973.
   PubMed Web of Science ®Google Scholar
• Lu YF, Pan LY, Zhang WW, et al. A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19. Int J Infect Dis. 2020 Aug 13;100:34–41.
   PubMed Web of Science ®Google Scholar
• Oxley TJ, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020 May 14;382(20):e60.
   PubMed Web of Science ®Google Scholar
• Hanif A, Khan S, Mantri N, et al. Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience. Ann Hematol. 2020 Aug 17;99(10):2323–2328.
   PubMed Web of Science ®Google Scholar
• ATTACC, ACTIV-4a & REMAP-CAP multiplatform RCT - Results of interim analysis [Presentation]. attacc.org: ATTACC; [updated January 28, 2021;March 6, 2021]. Available from: https://static1.squarespace.com/static/5f8f2c323fb81b0ae2ce3bca/t/60133c0962b8401f3885b537/1611873291651/mpRCT+interim+presentation_v21-slides+22+and+23+corrected+%281%29.pdf
   Google Scholar
• Nadkarni GN, Lala A, Bagiella E, et al. Anticoagulation, mortality, bleeding and pathology among patients hospitalized with COVID-19: a single health system study. J Am Coll Cardiol. 2020 Aug 24;76(16):1815–1826.
   PubMed Web of Science ®Google Scholar
• Antithrombotic therapy in patients with COVID-19: national Institutes of Health; 2020 [updated February 11, 2021;March 6, 2021]. Available from: https://www.covid19treatmentguidelines.nih.gov/antithrombotic-therapy/
   Google Scholar
• Poor HD, Ventetuolo CE, Tolbert T, et al. COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis. Clin Transl Med. 2020 May 13;10(2). DOI:10.1002/ctm2.44.
   PubMed Web of Science ®Google Scholar
• Buetti N, Ruckly S, De Montmollin E, et al. COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network. Intensive Care Med. 2021 Feb;47(2):180–187.
   PubMed Web of Science ®Google Scholar
• Rouzé A, Martin-Loeches I, Povoa P, et al. Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med. 2021 Feb;47(2):188–198.
   PubMed Web of Science ®Google Scholar
• Biran N, Ip A, Ahn J, et al. Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study. Lancet Rheumatol. 2020 Aug 14;2(10):e603–e612.
   PubMedGoogle Scholar
• Tabibi S, Tabibi T, Conic RRZ, et al. Therapeutic plasma exchange: a potential management strategy for critically ill COVID-19 patients. J Intensive Care Med. 2020;35(9):827–835.
   PubMed Web of Science ®Google Scholar
• Paolisso P, Bergamaschi L, D’Angelo EC, et al. Preliminary experience with low molecular weight heparin strategy in COVID-19 patients. Front Pharmacol. 2020;11:1124.
   PubMed Web of Science ®Google Scholar